M&A Analysis: November Deal Making Hits Whole New Low

13 Dec 2016

• By Catherine Longworth

M&A deal activity dropped dramatically in November with a mere six deals in the medtech industry, making November the weakest month of the year so far. The biggest deal of the month recorded was Edward Lifesciences $690m acquisition of Israeli start-up Valtech.

Merging Business Network-Business leaders in global agreement — November Saw M&A Deal Making Hitting Its Lowest Point For The Year So Far • Source: Shutterstock

Medtech mergers and acquisition activity hit its lowest point for the year in November with only six deals recorded on Medtech Insight'sM&A Tracker – significantly lower than the previous months and a sharp drop from the 19 deals carried out in November 2015.

While September's surge of activity had sparked hopes of a Q4 turnaround, November saw M&A activity wane considerably from October's...